Easton Pharmaceutica Stock Buy Hold or Sell Recommendation
| EAPH Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Easton Pharmaceutica is 'Strong Sell'. The recommendation algorithm takes into account all of Easton Pharmaceutica's available fundamental, technical, and predictive indicators you will find on this site.
Check out Easton Pharmaceutica Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide. In addition, we conduct extensive research on individual companies such as Easton and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Easton |
Execute Easton Pharmaceutica Buy or Sell Advice
The Easton recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Easton Pharmaceutica. Macroaxis does not own or have any residual interests in Easton Pharmaceutica or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Easton Pharmaceutica's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Easton Pharmaceutica Trading Alerts and Improvement Suggestions
| Easton Pharmaceutica generated a negative expected return over the last 90 days | |
| Easton Pharmaceutica has some characteristics of a very speculative penny stock | |
| Easton Pharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K. | |
| Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Bloomberg |
Easton Pharmaceutica Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (43.0) | 156.8K | 493.0K | 258K | 296.7K | 311.5K | |
| Net Income | (245.3K) | (169.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
| Change To Netincome | 10.9M | 163.2K | 434.5K | (267.8K) | (308.0K) | (292.6K) |
Easton Pharmaceutica Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Easton Pharmaceutica or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Easton Pharmaceutica's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Easton stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Easton Pharmaceutica Volatility Alert
At this time Easton Pharmaceutica exhibits very low volatility. Easton Pharmaceutica appears to be a penny stock. Although Easton Pharmaceutica may be, in fact, a solid short-term or long term investment, many penny stocks are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Easton Pharmaceutica or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Easton instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Easton Pharmaceutica Fundamentals Vs Peers
Comparing Easton Pharmaceutica's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Easton Pharmaceutica's direct or indirect competition across all of the common fundamentals between Easton Pharmaceutica and the related equities. This way, we can detect undervalued stocks with similar characteristics as Easton Pharmaceutica or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Easton Pharmaceutica's fundamental indicators could also be used in its relative valuation, which is a method of valuing Easton Pharmaceutica by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Easton Pharmaceutica to competition |
| Fundamentals | Easton Pharmaceutica | Peer Average |
| Return On Equity | -0.0269 | -0.31 |
| Return On Asset | -0.0083 | -0.14 |
| Current Valuation | 2.14 M | 16.62 B |
| Shares Outstanding | 1.34 B | 571.82 M |
| Price To Earning | (22.00) X | 28.72 X |
| Price To Book | 0 X | 9.51 X |
| Price To Sales | 0.06 X | 11.42 X |
| Gross Profit | 201.4 K | 27.38 B |
| EBITDA | (188.54 K) | 3.9 B |
| Net Income | (188.54 K) | 570.98 M |
| Cash And Equivalents | 5.81 K | 2.7 B |
| Total Debt | 3.28 M | 5.32 B |
| Debt To Equity | 0.43 % | 48.70 % |
| Current Ratio | 0.69 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (188.54 K) | 971.22 M |
| Beta | 15.58 | -0.15 |
| Market Capitalization | 134.49 K | 19.03 B |
| Total Asset | 10.19 M | 29.47 B |
| Retained Earnings | (39.82 M) | 9.33 B |
| Working Capital | (194.5 K) | 1.48 B |
| Current Asset | 297 K | 9.34 B |
| Current Liabilities | 137 K | 7.9 B |
| Net Asset | 10.19 M |
Easton Pharmaceutica Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Easton . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Easton Pharmaceutica Buy or Sell Advice
When is the right time to buy or sell Easton Pharmaceutica? Buying financial instruments such as Easton Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Easton Pharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Food Products Thematic Idea Now
Food Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Easton Pharmaceutica Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.